Open AccessA Comparative Study on Weekly Versus Three Weekly Cisplatinum Based Chemoradiation in Locally Advanced Head and Neck Cancers
Author(s) -
Tapan Kumar Sahoo,
Dipti Rani Samanta,
Surendra Nath Senapati,
Karishma Parida
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/24765.9293
Subject(s) - medicine , mucositis , leukopenia , neutropenia , vomiting , radiation therapy , cisplatin , nausea , rash , surgery , oncology , chemotherapy
Head and Neck Cancers constitute around 30% of cancers occurring in India and majority of cases present with locoregionally advanced disease. Cisplatin based concurrent chemoradiation is the most common modality of definitive treatment in these advanced cases. However, it is unclear regarding priority of weekly versus three weekly cisplatin based concurrent chemoradiation schedule in treatment of such advanced diseases.